A majority of GEN poll takers predicts at least some usefulness from President Barack Obama’s recently released National Bioeconomy Blueprint, detailing measures by which Washington intends to apply biological research innovations toward national challenges that include health, food, energy, and the environment. Exactly one-third (33.3%) of respondents said they thought the Blueprint would be “very” useful, while just over one-quarter (25.9%) said it would be “somewhat” useful. However, roughly another one-third (31.5%) concluded that the Blueprint was “not very” useful. The remaining 9.3% was undecided.

The Blueprint’s five priorities include supporting “R&D investments that will provide the foundation for the future U.S. bioeconomy,” followed by increasing the focus on translational and regulatory sciences, reforming regulations, updating training programs, and identifying and supporting opportunities for public-private partnerships.

Previous articleOsiris Wins Race to Market a Stem Cell Product with Canadian Go-Ahead
Next articleBio-Rad Squashes Idea That the Company Is Up for Grabs